Recent studies have reported that reduction of leucine levels inhibited proliferation of ER+ (breast cancers that express estrogen receptors) breast cancer cells, whereas increased leucine levels enhanced proliferation of ER+ breast cancer cells. This evidence concerns the gene ESR1 and breast cancer.